Hemlibra 105 MG/0.7 ML vial 0.7ML
Ended Awarded
- Contract number
- SPE2DB26FX1JN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,250
Award facts
- Contract value 100% obligated
- $13,250.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On October 8, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $13,250.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, contract number 4569725009, calls for the supply of HEMLIBRA 105 mg/0.7 mL vials. The contract was awarded without a set-aside designation, and performance is scheduled for completion by October 30, 2025, with the place of performance located in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award vehicle valued at $499,999,999 and valid through November 2026. The parent contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, with a track record of consistent delivery orders for specialized pharmaceutical products supporting military health systems nationwide.
Quick answers
Who was awarded contract SPE2DB26FX1JN?
SPE2DB26FX1JN was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 8, 2025.
How much is contract SPE2DB26FX1JN worth?
The government has obligated $13,250 on SPE2DB26FX1JN.
Is contract SPE2DB26FX1JN an order under another contract?
Yes. SPE2DB26FX1JN is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB26FX1JN competed?
The extent of competition for SPE2DB26FX1JN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award